MedicarePartD.guide

A non-government resource built from CMS public data

Non-statin cholesterol drugs on HealthSpring Assurance Rx (S5617-221)

Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Michigan
Premium
$0.00/month
Deductible
$615.00
Change plan

5 of 8 Non-statin cholesterol drugs are covered on this plan. 2 of them require prior authorization.

3 aren't on the formulary, including Praluent and Nexlizet.

Not on the formulary
Praluent, Nexlizet, Vascepa

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list